Evidence map›Paper›PMID 32153413›Full record

ArticleFrontiers in pharmacology2020

The Regulator of G Protein Signaling Homologous Domain of G Protein-Coupled Receptor Kinase 2 Mediates Short-Term Desensitization of β3-Adrenergic Receptor.

Emiliana Echeverría, Maia Cabrera, Valeria Burghi, Máximo Sosa, Sonia Ripoll, Agustín Yaneff, Federico Monczor, Carlos Davio, Carina Shayo, Natalia Fernández

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Emiliana EcheverríaFacultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Maia CabreraFacultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Valeria BurghiFacultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Máximo SosaFacultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Sonia RipollFacultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Agustín YaneffFacultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Federico MonczorFacultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Carlos DavioFacultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Carina ShayoLaboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental (IByME), CONICET, Buenos Aires, Argentina.
Natalia FernándezFacultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
University of Buenos Aires · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARExperimental Medicine and Biology Institute · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

G protein coupled receptor (GPCR) kinases (GRKs) are key regulators of GPCR signaling. Canonical mechanism of GPCR desensitization involves receptor phosphorylation by GRKs followed by arrestin recruitment and uncoupling from heterotrimeric G protein. Although β3-adrenergic receptor (β3AR) lacks phosphorylation sites by GRKs, agonist treatment proved to induce β3AR desensitization in many cell types. Here we show that GRK2 mediates short-term desensitization of β3AR by a phosphorylation independent mechanism but mediated by its domain homologous to the regulator of G protein signaling (RGS). HEK293T cells overexpressing human β3AR presented a short-term desensitization of cAMP response stimulated by the β3AR agonist, BRL37344, and not by forskolin. We found that β3AR desensitization was higher in cells co-transfected with GRK2. Similarly, overexpression of the RGS homology domain but not kinase domain of GRK2 increased β3AR desensitization. Consistently, stimulation of β3AR increased interaction between GRK2 and Gαs subunit. Furthermore, in rat cardiomyocytes endogenously expressing β3AR, transfection with dominant negative mutant of RH domain of GRK2 (GRK2/D110A) increased cAMP response to BRL37344 and inhibited receptor desensitization. We expect our study to be a starting point for more sophisticated characterization of the consequences of GRK2 mediated desensitization of the β3AR in heart function and disease.

Indexed as

cardiomyocytesdesensitizationGRK2RGSβ3AR

Identifiers

PMID32153413
PMCPMC7047201
OpenAlexW3007873705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.